YZR Capital is a founder-led venture capital firm focused on healthcare innovation in Europe, investing in startups from pre-seed to Series B stages. Their strategy involves partnering with founders to build global champions that enhance healthcare efficiency, transparency, and accessibility, with a focus on areas like Digital & Consumer health, Health Data, Healthcare Systems & Infrastructure, and MedTech & Devices.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (83% of deals). Average disclosed round size is $6.3M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$100M
Top Stage
Seed
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| SScripta Therapeutics | Seed | $12M | Nov 2025 |
| HHoli | Seed | $3M | Nov 2025 |
 Doctor.One | Seed | $4M | Sep 2025 |
| DDeepLife | Series A | $10M | Dec 2024 |
| Cclare&me | Seed | $3.7M | Aug 2024 |
| EEsper Bionics | Seed | $5M | Jun 2024 |
Top Co-Investors
4growth VC1 shared
business angel1 shared
EBRD1 shared
Beiersdorf1 shared
Antler1 shared
Oxford Science Enterprises1 shared
AlbionVC1 shared
Apollo Health Ventures1 shared
Last updated: 28 April 2026